Keiichi Kinowaki

7PUBLICATIONS
12CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2026
Hepatocellular Carcinoma Arising From Well-Differentiated Hepatocellular Neoplasm of Uncertain Malignant Potential in a Patient With Abernethy Malformation.

|Jul 07, 2022
Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumab.

Michikata Hayashida, Yuji Miura, Taisho Noda

|Feb 17, 2022
TRIM39 is a poor prognostic factor for patients with estrogen receptor-positive breast cancer and promotes cell cycle progression.

Takuya Ogura, Kotaro Azuma, Toshihiko Takeiwa

|Nov 13, 2021
OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.

Takuya Ogura, Kotaro Azuma, Junichiro Sato

|Nov 10, 2021
Cystic partially differentiated nephroblastoma in a 74-year-old patient.

Michikata Hayashida, Shoichi Nagamoto, Akihiro Yano

|Nov 07, 2020
Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.

Junichiro Sato, Kotaro Azuma, Keiichi Kinowaki

Pageof 2

Frequent Collaborators

3 joint publications

Satoshi Inoue

2 joint publications

Michikata Hayashida

1 joint publications

Masanobu Kitagawa

1 joint publications

Takuya Ogura